Literature DB >> 15902387

[60 year old patient with soft tissue infection of the right leg].

D Hasper1, D Schrage, K-D Schaser, I Melcher, D Barckow, U Frei, M Oppert.   

Abstract

Group A streptococcal necrotizing fasciitis is a rare disease associated with high mortality. Since severe toxic shock syndrome is a common complication, only immediate and aggressive surgical intervention, adequate antimicrobial therapy and supportive intensive care can be life-saving. We report about successful treatment of a 60-year old patient with necrotizing fasciitis and multiple organ failure.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15902387     DOI： 10.1007/s00108-005-1429-2

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN： 0020-9554            Impact factor:   0.743


  12 in total

1.  Experimental approach to the problem of treatment failure with penicillin. I. Group A streptococcal infection in mice.

Authors:  H EAGLE
Journal:  Am J Med       Date:  1952-10       Impact factor: 4.965

2.  Intravenous immunoglobulin therapy for toxic shock syndrome.

Authors:  W Barry; L Hudgins; S T Donta; E L Pesanti
Journal:  JAMA       Date:  1992-06-24       Impact factor: 56.272

3.  Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group.

Authors:  R Kaul; A McGeer; A Norrby-Teglund; M Kotb; B Schwartz; K O'Rourke; J Talbot; D E Low
Journal:  Clin Infect Dis       Date:  1999-04       Impact factor: 9.079

4.  Efficacy and safety of recombinant human activated protein C for severe sepsis.

Authors:  G R Bernard; J L Vincent; P F Laterre; S P LaRosa; J F Dhainaut; A Lopez-Rodriguez; J S Steingrub; G E Garber; J D Helterbrand; E W Ely; C J Fisher
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

5.  Necrotising fasciitis.

Authors:  J M Yong
Journal:  Lancet       Date:  1994-06-04       Impact factor: 79.321

6.  Population-based surveillance for group A streptococcal necrotizing fasciitis: Clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Ontario Group A Streptococcal Study.

Authors:  R Kaul; A McGeer; D E Low; K Green; B Schwartz
Journal:  Am J Med       Date:  1997-07       Impact factor: 4.965

7.  Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection.

Authors:  J Zimbelman; A Palmer; J Todd
Journal:  Pediatr Infect Dis J       Date:  1999-12       Impact factor: 2.129

8.  Evidence for the presence of streptococcal-superantigen-neutralizing antibodies in normal polyspecific immunoglobulin G.

Authors:  A Norrby-Teglund; R Kaul; D E Low; A McGeer; J Andersson; U Andersson; M Kotb
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

9.  Potentiation of opsonization and phagocytosis of Streptococcus pyogenes following growth in the presence of clindamycin.

Authors:  C G Gemmell; P K Peterson; D Schmeling; Y Kim; J Mathews; L Wannamaker; P G Quie
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

10.  Penicillin-binding protein expression at different growth stages determines penicillin efficacy in vitro and in vivo: an explanation for the inoculum effect.

Authors:  D L Stevens; S Yan; A E Bryant
Journal:  J Infect Dis       Date:  1993-06       Impact factor: 5.226
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.